Search for company
Explore more than 1.3 million company profiles from emerging markets

Galenika A.D. (Serbia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Select Items to chart them. 2013 Y
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
Net Profit(Loss)
Total Assets 16,791,867
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Poslovni Plan DOO, EMIS Company Database.
Company Description

Galenika, a state-controlled firm established in 1945, was the first company in former Yugoslavia to be acquired by a foreign partner.
ICN Pharmaceuticals, which acquired a 75% stake in the drug maker under a 1990 agreement, planned to use it as a platform for growth in eastern Europe.
California-based ICN was owned at the time by Serb-born U.S. businessman Milan Panic, who returned to his native country in 1992 to briefly serve as Prime Minister.
Serbia's government took over the Belgrade plant of…

Contact Information

Batajnicki Drum Bb
Belgrade; Belgrade; Map
Postal Code: 11080
Tel: (+381 11) 307 10 00
Fax: (+381 11) 307 16 70

Full name: Galenika A.D. Beograd

Status: Non-Listed
Legal Form: Joint Stock Company
Operational Status: Operational
YU-MB: 07726325
PIB: 100001038
Incorporation Date: 30-Apr-91

Basic Information
Total Employees:
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:
Key Executives
Chairman of the Supervisory Board
Ownership Details
Republic of Serbia
Affiliates and related companies
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - Serbia

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.